- Home
- PLBY vs XGN Comparison
PLBY vs XGN Comparison
Compare PLBY & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- XGN
- Stock Information
- Founded
- PLBY 1953
- XGN 2002
- Country
- PLBY United States
- XGN United States
- Employees
- PLBY N/A
- XGN N/A
- Industry
- PLBY Recreational Games/Products/Toys
- XGN Medical Specialities
- Sector
- PLBY Consumer Discretionary
- XGN Health Care
- Exchange
- PLBY Nasdaq
- XGN Nasdaq
- Market Cap
- PLBY 53.2M
- XGN 44.7M
- IPO Year
- PLBY N/A
- XGN 2019
- Fundamental
- Price
- PLBY $1.16
- XGN $2.98
- Analyst Decision
- PLBY Buy
- XGN Buy
- Analyst Count
- PLBY 2
- XGN 1
- Target Price
- PLBY $2.35
- XGN $7.00
- AVG Volume (30 Days)
- PLBY 8.4M
- XGN 21.5K
- Earning Date
- PLBY 11-12-2024
- XGN 11-12-2024
- Dividend Yield
- PLBY N/A
- XGN N/A
- EPS Growth
- PLBY N/A
- XGN N/A
- EPS
- PLBY N/A
- XGN N/A
- Revenue
- PLBY $72,188,000.00
- XGN $55,751,000.00
- Revenue This Year
- PLBY N/A
- XGN $9.98
- Revenue Next Year
- PLBY N/A
- XGN $13.63
- P/E Ratio
- PLBY N/A
- XGN N/A
- Revenue Growth
- PLBY N/A
- XGN 8.00
- 52 Week Low
- PLBY $0.44
- XGN $1.30
- 52 Week High
- PLBY $1.55
- XGN $3.71
- Technical
- Relative Strength Index (RSI)
- PLBY 59.27
- XGN 58.94
- Support Level
- PLBY $0.85
- XGN $2.62
- Resistance Level
- PLBY $1.14
- XGN $2.97
- Average True Range (ATR)
- PLBY 0.19
- XGN 0.21
- MACD
- PLBY -0.00
- XGN 0.05
- Stochastic Oscillator
- PLBY 53.85
- XGN 83.33
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.